| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 711739 | Null | 3.88440367201721e-005 | 0.62291701 |
| NSC 735333 | Null | 3.88440367201721e-005 | 0.66446316 |
| NSC 603974 | Null | 4.20634348588214e-005 | 0.69263891 |
| NSC 618201 | 1,4-Anthracenedione, 5-hydroxy- | 4.20634348588214e-005 | 0.74952135 |
| NSC 658828 | Null | 4.20634348588214e-005 | 0.6892723 |
| NSC 671189 | Null | 4.20634348588214e-005 | 0.42197245 |
| NSC 659936 | Null | 4.35666174401502e-006 | 0.72021628 |
| NSC 708048 | 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- | 4.54580437744686e-005 | 0.81288318 |
| NSC 709362 | Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- | 4.54580437744686e-005 | 0.83324064 |
| NSC 603084 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- | 4.5458043774469e-005 | 0.70505097 |